Home/Filings/4/0001213900-25-011409
4//SEC Filing

ATWOOD BRIAN G 4

Accession 0001213900-25-011409

CIK 0001870404other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 5:23 PM ET

Size

13.3 KB

Accession

0001213900-25-011409

Insider Transaction Report

Form 4
Period: 2025-02-07
Transactions
  • Award

    Warrant to Purchase Shares of Common Stock

    2025-02-07$1.96/sh+306,120$599,965306,120 total
    Exercise: $1.96Common Stock (306,120 underlying)
  • Award

    Pre-Funded Warrant

    2025-02-07$0.00/sh+306,120$31306,120 total
    Exercise: $0.00From: 2025-02-07Common Stock (306,120 underlying)
  • Award

    Pre-Funded Warrant

    2025-02-07$0.00/sh+204,080$20204,080 total(indirect: By LLC)
    Exercise: $0.00From: 2025-02-07Common Stock (204,080 underlying)
  • Award

    Warrant to Purchase Shares of Common Stock

    2025-02-07$1.96/sh+204,080$399,976204,080 total(indirect: By LLC)
    Exercise: $1.96Common Stock (204,080 underlying)
Footnotes (2)
  • [F1]On February 7, 2025, pursuant to a Securities Purchase Agreement, dated February 5, 2025, the reporting persons purchased Pre-Funded Warrants, which are exercisable at any time on or after the date of issuance for an exercise price of $0.0001 per share, for shares of common stock of CERo Therapeutics Holdings, Inc. (the "Issuer"), and an equal number of Warrants, which will become exercisable immediately upon the Issuer's receipt of stockholder approval (the "Stockholder Approval Date") for an exercise price of $1.96 per share, for shares of the Issuer's common stock. The aggregate purchase price for each pair of Pre-Funded Warrants and Warrants was $1.9599. The Warrants will expire on the fifth anniversary of the Stockholder Approval Date.
  • [F2]GVN, LLC (the "LLC") is a limited liability company of which the sole member is the Atwood-Edminster Trust dtd 4-2-2000 (the "Trust"). Mr. Atwood and his wife are the managers of the LLC and the trustees of the Trust. Accordingly, Mr. Atwood may be deemed to have beneficial ownership of the securities held directly by the LLC.

Documents

1 file

Issuer

CERO THERAPEUTICS HOLDINGS, INC.

CIK 0001870404

Entity typeother

Related Parties

1
  • filerCIK 0001266567

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 5:23 PM ET
Size
13.3 KB